Logo - springer
Slogan - springer

Medicine - Oncology & Hematology | Journal of Experimental & Clinical Cancer Research

Journal of Experimental & Clinical Cancer Research

Journal of Experimental & Clinical Cancer Research

Editor-in-Chief: Mauro Castelli
Managing Editor: Alice Castelli

ISSN: 1756-9966 (electronic version)

Journal no. 13046

BioMed Central

Open access BioMed Central
Learn more about the metrics of this journal
  • ·         Ranked in the 1st quartile of oncology journals in Journal Citation Reports
  • ·         Rapid peer review - average first decision within 30 days
  • ·        Open access: freely and permanently available online to foster an active academic exchange

Journal of Experimental and Clinical Cancer Research is ranked in the first quartile of oncology journals in Journal Citation Reports and is the official journal of the Regina Elena National Cancer Institute. Publishing high-quality multidisciplinary research on all aspects of basic, clinical and translational oncology studies, the journal is a valuable resource for oncologists and researchers alike. The open access platform provides visibility on a global scale and makes an impact in real time, with the journal providing authors with a first decision after submission within 30 days.

Related subjects » Cancer Research - Cell Biology - Immunology - Oncology & Hematology

Impact Factor: 6.217 (2017) * 

Journal Citation Reports®

Abstracted/Indexed in 

Science Citation Index Expanded (SciSearch), Journal Citation Reports/Science Edition, Medline, PubMedCentral, SCOPUS, EMBASE, Chemical Abstracts Service (CAS), Google Scholar, CNKI, Current Abstracts, DOAJ, EBSCO Academic Search, EBSCO Biomedical Reference Collection, EBSCO Discovery Service, EBSCO STM Source, EBSCO TOC Premier, Expanded Academic, Health Reference Center Academic, OCLC WorldCat Discovery Service, Pathway Studio, ProQuest-ExLibris Primo, ProQuest-ExLibris Summon, Reaxys

Read This journal on BioMed Central

For authors and editors

  • Journal Citation Reports®
    2017 Impact Factor
  • 6.217
  • Aims and Scope

    Aims and Scope


    Journal of Experimental & Clinical Cancer Research is an online peer-reviewed journal that publishes original research papers, reviews and commentaries in cancer research, from bench to bedside.

    Journal of Experimental & Clinical Cancer Research seeks manuscripts that include significant advances in basic cancer research and that offer a translational bridge from the laboratory to the clinic to open new avenues for the understanding, prevention, diagnosis and treatment of cancer.

    Specific areas of interest include, but are not limited to: mechanisms of progression of the malignant phenotype and metastatic disease; molecular alterations or biomarkers that predict response or resistance to treatment; translational research in targeted therapies; personalized medicine; novel applications of bioinformatics and biostatistics; tumor immunotherapy; large-scale molecular characterization of human tumors and innovative methods with potential applicability to clinical investigation.

    The following criteria provide an overview of the types of studies considered by the journal:

    • Findings that have not been previously published in the same tumor model.
    • Studies performed in multiple cell lines.
    • Conclusions that are not representative of incremental findings.
    • Studies that include a clearly written title and abstract that communicate the study's impact of significance to non-experts.

    The online appearance of Journal of Experimental & Clinical Cancer Research allows the immediate publication of accepted articles and the presentation of large amounts of data and supplemental information to ensure that new research is disseminated as efficiently and quickly as possible to the scientific community.

  • Submit Online
  • English Language Editing

    English Language Editing


  • Writing Resources: Training for Authors